SCHEMBL20060663

SCHEMBL20060663

CCCCc1cc(NC(=O)Nc2ccc(Oc3ccnc(NC(=O)N4CCOCC4)c3)c3ccccc23)n(-c2ccc(C)cc2)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 15/20 0.60
MAPK12 P53778 7/20 0.60
SRC P12931 13/20 0.58
GSK3A P49840 13/20 0.58
SYK P43405 11/20 0.58
HCK P08631 4/20 0.58
GSK3B P49841 2/20 0.58
MAPK13 O15264 2/20 0.53
MAPK11 Q15759 2/20 0.53
CIT O14578 1/20 0.52
MUSK O15146 1/20 0.52
MAP3K7 O43318 1/20 0.52
RIPK2 O43353 1/20 0.52
STK10 O94804 1/20 0.52
MAP4K4 O95819 1/20 0.52
CHEK2 O96017 1/20 0.52
ABL1 P00519 1/20 0.52
EGFR P00533 1/20 0.52
TNF P01375 1/20 0.52
RAF1 P04049 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20663703 0.94 MAPK14 (0.57) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20060707 0.94 MAPK14 (0.61) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20060692 0.93 MAPK14 (0.60) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20663740 0.93 MAPK14 (0.52) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20060670 0.92 MAPK14 (0.65) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20663682 0.91 TNF (0.55) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20036763 0.90 MAPK14 (0.67) MAPK14MAPK12SRCHCKGSK3B
SCHEMBL20060666 0.90 MAPK14 (0.60) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20060700 0.90 MAPK14 (0.64) MAPK14MAPK12SRCGSK3ASYK
SCHEMBL20663717 0.89 MAPK14 (0.54) MAPK14MAPK12SRCGSK3ASYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582433-B1 UREIDO-PYRAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF RHINOVIRUS INFECTIONS RESPIVERT LTD (GB) 2018-04-18 EP disclosed